We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Offers Recommendations on Distributing New Risk Info to Doctors
Guidance Offers Recommendations on Distributing New Risk Info to Doctors
Drugmakers may distribute new risk information to physicians on approved products if they meet a set of standards around the validity of the information, the FDA said in its latest effort to relax limits on the distribution of journal articles and other texts to prescribers.